Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neoplasms
|
98 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.730 | 1.000 | 1 | 2014 | 2017 | ||||||
melanoma
|
212 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.720 | 1.000 | 0 | 2016 | 2018 | ||||||
Thyroid Neoplasm
|
25 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 5 | 2007 | 2016 | ||||||
Squamous cell carcinoma of skin
|
67 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 4 | 2012 | 2016 | ||||||
Adenocarcinoma of lung (disorder)
|
404 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adenocarcinoma of pancreas
|
114 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adenocarcinoma of prostate
|
96 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Chronic Lymphocytic Leukemia
|
183 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Colorectal Neoplasms
|
586 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Cutaneous Melanoma
|
195 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Gastric Adenocarcinoma
|
220 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Leukemia, Myelocytic, Acute
|
6669 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Liver carcinoma
|
203 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Malignant Uterine Corpus Neoplasm
|
152 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Mammary Neoplasms
|
316 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Multiple Myeloma
|
760 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Squamous cell carcinoma of lung
|
248 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Squamous cell carcinoma of the head and neck
|
182 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Transitional cell carcinoma of bladder
|
141 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Nevus Sebaceus of Jadassohn
|
7 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 0 | |||||||||
Organoid Nevus Phakomatosis
|
7 | 0.627 | 0.520 | 11 | 533874 | missense variant | T/A;C;G | snv | 0.700 | 0 |